David Alker
Impact in
- Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis
- Asymmetric Synthesis and Catalysis
- Synthesis and Catalytic Reactions
- Synthetic Organic Chemistry Methods
- Chemical Reaction Mechanisms
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Carbohydrate Chemistry and Synthesis 7
- Asymmetric Synthesis and Catalysis 4
- Chemical Reaction Mechanisms 4
- Synthesis and Biological Evaluation 4
- Synthesis of heterocyclic compounds 3
- Synthesis and Reactivity of Heterocycles 3
- Synthesis and Catalytic Reactions 3
- Co-authors
- Peter R. AshtonRainer KönigerJ. Fraser StoddartLaurence M. HarwoodSimon F. CampbellPeter E. CrossRoger A. BurgesDonald G. Gardiner
- Journals
- Journal of the Chemical Society Perkin Transactions 1 (6 papers)Tetrahedron Letters (4 papers)Journal of Medicinal Chemistry (4 papers)Tetrahedron (3 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United KingdomUnited States
In The Last Decade
David Alker
26 papers receiving 555 citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Organic Chemistry 394
- Pharmaceutical Science 65
- Spectroscopy 86
- Molecular Biology 254
- Electrochemistry 15
Countries citing papers authored by David Alker
This map shows the geographic impact of David Alker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Alker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Alker more than expected).
Fields of papers citing papers by David Alker
This network shows the impact of papers produced by David Alker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Alker. The network helps show where David Alker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Alker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 24 | |
| 2 | 1998 | 34 | |
| 3 | 1997 | 12 | |
| 4 | Amino Acid Derivatives of β-Cyclodextrin Hit paper breakdown → | 1996 | 245 |
| 5 | 1994 | 7 | |
| 6 | 1994 | 13 | |
| 7 | 1993 | 6 | |
| 8 | 1992 | 1 | |
| 9 | 1992 | 5 | |
| 10 | 1991 | 13 | |
| 11 | 1991 | 5 | |
| 12 | 1990 | 28 | |
| 13 | 1990 | 23 | |
| 14 | 1990 | 54 | |
| 15 | 1990 | 8 | |
| 16 | 1990 | 8 | |
| 17 | 1990 | 1 | |
| 18 | 1990 | 2 | |
| 19 | 1990 | 10 | |
| 20 | 1989 | 25 |
About David Alker
David Alker is a scholar working on Organic Chemistry, Pharmaceutical Science, Analytical Chemistry, Pharmacology and Biochemistry, having authored 26 papers that have together received 599 indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (7 papers), Asymmetric Synthesis and Catalysis (4 papers), Chemical Reaction Mechanisms (4 papers), Synthesis and Biological Evaluation (4 papers), Synthesis of heterocyclic compounds (3 papers), Chemical Synthesis and Analysis (3 papers), Synthesis and Reactivity of Heterocycles (3 papers) and Synthesis and Catalytic Reactions (3 papers). The work is most often cited by research in Organic Chemistry (394 citations), Pharmaceutical Science (65 citations), Spectroscopy (86 citations), Molecular Biology (254 citations) and Electrochemistry (15 citations). David Alker has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Peter R. Ashton, Rainer Königer, J. Fraser Stoddart, Laurence M. Harwood, Simon F. Campbell, Peter E. Cross, Roger A. Burges, Donald G. Gardiner, Kevin Doyle and Andrew McGregor. Their work appears in journals such as Journal of the Chemical Society Perkin Transactions 1, Tetrahedron Letters, Journal of Medicinal Chemistry, Tetrahedron and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.